Brief: Bausch + Lomb Study Reviews B Vitamins' Impact on Macular Degeneration
23/04/2026 12:03
April 23 (Reuters) - Bausch + Lomb Corp BLCO.TO: BAUSCH + LOMB ANNOUNCES PUBLISHED REVIEW EXAMINING THE ROLE OF B VITAMINS IN REDUCING RISK AND PROGRESSION OF AGE-RELATED MACULAR DEGENERATION Source text: ID:nBw6sLWW4a Further company coverage: BLCO.TO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bausch + Lomb
See all newsBausch + Lomb CEO Saunders departs, Chairman Appio named interim chief (updated)
Brief: Bausch + Lomb And Bausch Health Announce Appointment Of Thomas J. Appio As Interim Bausch + Lomb CEO, Expect To Raise Full-Year 2026 Guidance
Bausch + Lomb CEO Saunders steps down, Chairman Appio appointed interim chief
Brief: US FDA sent warning letter to Bausch & Lomb on September 4
Brief: Bausch + Lomb Announces European CE Mark Approval Of Seelyra™ Femtosecond Laser